(Q35545068)

8 August 2017

1 reference

title

Many and multiple myeloma(s) (English)

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.LEU.2403090

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513042

chromosomal translocation

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513042

15 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403090

15 March 2024

R. Fonseca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513042

15 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14513042

15 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://www.nature.com/articles/2403090.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513042

https://www.nature.com/articles/2403090.pdf

15 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403090

https://www.nature.com/articles/2403090

15 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.LEU.2403090

15 March 2024

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

1943-1944

1 reference

Mutations of mitotic checkpoint genes in human cancers

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Clinical and biologic implications of recurrent genomic aberrations in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Multiple myeloma: evolving genetic events and host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

The (11;14)(q13;q32) Translocation in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

Cytogenetic findings in 200 patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

Hypodiploidy is a major prognostic factor in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403090

7 January 2021

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403090

15 March 2024

Identifiers

DOI

1 reference

release_l3t5ldfcbvguzfzqdnestc64we

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l3t5ldfcbvguzfzqdnestc64we

24 November 2022

mapped directly with Wikidata item

1 reference